Status:

RECRUITING

Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function

Lead Sponsor:

Northwestern University

Conditions:

Overactive Bladder (OAB)

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.

Detailed Description

OBJECTIVES: Null hypothesis - Ingesting 1000mg daily of Cucurbita pepo pumpkin seed oil extract leads to no change in patient-reported bladder function reflected through Lower Urinary Tract Dysfuncti...

Eligibility Criteria

Inclusion

  • All patients evaluated at Northwestern's IPHP who report bladder function consistent with overactive bladder (urinary urgency, with or without urinary frequency more than 8 times daily or nocturia, with or without urgency urinary incontinence) at their index visit, who are also willing to use a dietary supplement and not initiate additional behavioral, medication or procedural treatment for 12 weeks following pumpkin seed oil extract initiation.

Exclusion

  • Patients with any of the following will be excluded from the study:
  • Use of other supplements that contain pumpkin seed oil
  • ≥Stage 3 pelvic organ prolapse
  • Urinary post-void residual ≥150cc
  • Culture-proven urinary tract infection at time of study enrollment
  • Recurrent urinary tract infection
  • Neurogenic bladder
  • Abdominal or pelvic malignancy
  • Initiation of new overactive bladder medications or supplements during study period or in the 3 months immediately preceding study enrollment
  • History of surgery in the past 12 months for pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, or fecal or flatal incontinence
  • Patient's primary language is not English

Key Trial Info

Start Date :

April 11 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06944392

Start Date

April 11 2025

End Date

July 1 2026

Last Update

April 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University

Chicago, Illinois, United States, 60611